.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Covington
Cipla
Colorcon
Citi
Fuji
Accenture
Baxter
McKinsey
AstraZeneca

Generated: December 16, 2017

DrugPatentWatch Database Preview

FENTANYL-62 Drug Profile

« Back to Dashboard

When do Fentanyl-62 patents expire, and what generic alternatives are available?

Fentanyl-62 is a drug marketed by Mylan Technologies and is included in one NDA.

The generic ingredient in FENTANYL-62 is fentanyl. There are thirty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the fentanyl profile page.
Drug patent expirations by year for FENTANYL-62

Pharmacology for FENTANYL-62

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

Medical Subject Heading (MeSH) Categories for FENTANYL-62

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan TechnologiesFENTANYL-62fentanylFILM, EXTENDED RELEASE;TRANSDERMAL076258-007Dec 29, 2014RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Teva
Chinese Patent Office
Baxter
Cerilliant
Dow
Argus Health
US Department of Justice
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot